# Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection

> **NCT05585684** · — · RECRUITING · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 150 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **OTHER:** Non-invasive Comprehensive Genomic Profiling for Cancer Treatment Selection

## Key facts

- **NCT ID:** NCT05585684
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-27
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05585684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05585684, "Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05585684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*